Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Helius Medical Technologies Stock Quote

Helius Medical Technologies (NASDAQ: HSDT)

$1.63
(-4.1%)
-$0.07
Price as of May 10, 2024, 4:00 p.m. ET

Helius Medical Technologies Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HSDT -81.07% -99.95% -78.45% -100%
S&P +26.44% +81.25% +12.62% +163%

Helius Medical Technologies Company Info

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.